Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.2
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 28826672
Wang ZH, et al. (2017) Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease. Mol Cell 67, 812-825.e5 28826672
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S226-p - LGMN (human)
Modsite: CYYDEkRsTYLGDWY SwissProt Entrez-Gene
Orthologous residues
LGMN (human): S226‑p, LGMN iso3 (human): S226‑p, LGMN (mouse): G228‑p, LGMN (rat): S228‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  293FT, brain, HeLa (cervical)
Cellular systems studied:  cell lines, tissue
Species studied:  human, mouse, rat
Enzymes shown to modify site in vitro
Type Enzyme
KINASE SRPK2 (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE SRPK2 (human) microscopy-colocalization, transfection of constitutively active enzyme, co-immunoprecipitation, transfection of wild-type enzyme
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced
Comments:  AD Pathologies in Young 3xTg mice, stimulating cognitive dysfunction
Associated Diseases
Diseases Alterations Comments
Alzheimer's disease increased

T492-p - SRPK2 (human)
Modsite: PSHDRSRtVsAsstG SwissProt Entrez-Gene
Orthologous residues
SRPK2 (human): T492‑p, SRPK2 iso2 (human): T503‑p, SRPK2 (mouse): T485‑p, SRPK2 (rat): T485‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  293FT, brain, HeLa (cervical)
Cellular systems studied:  cell lines, tissue
Species studied:  human, mouse, rat
Associated Diseases
Diseases Alterations Comments
Alzheimer's disease increased

S228-p - LGMN (rat)
Modsite: CYYDEERsTYLGDWY SwissProt Entrez-Gene
Orthologous residues
LGMN (human): S226‑p, LGMN iso3 (human): S226‑p, LGMN (mouse): G228‑p, LGMN (rat): S228‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  293FT, brain, HeLa (cervical)
Cellular systems studied:  cell lines, tissue
Species studied:  human, mouse, rat

T485-p - SRPK2 (rat)
Modsite: PSRDRSRtVsASstG GenPept Entrez-Gene
Orthologous residues
SRPK2 (human): T492‑p, SRPK2 iso2 (human): T503‑p, SRPK2 (mouse): T485‑p, SRPK2 (rat): T485‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  293FT, brain, HeLa (cervical)
Cellular systems studied:  cell lines, tissue
Species studied:  human, mouse, rat